This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Colossal Biosciences Edits Mouse Genes
Tech genetic engineering

Colossal Biosciences Edits Mouse Genes

Analysis based on 6 articles · First reported Mar 04, 2025 · Last updated Mar 06, 2025

Sentiment
60
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The successful gene editing by Colossal Biosciences in mice demonstrates significant technological advancement in biotechnology, potentially boosting investor confidence in the company and the broader gene-editing sector. This could lead to increased investment in related fields like healthcare and animal agriculture, as the technology has applications beyond de-extinction.

Biotechnology Healthcare Agriculture
Event Summary

Colossal Biosciences, a biotech company, announced a significant breakthrough in its de-extinction efforts by successfully editing seven genes in Mouse embryos to create mice with long, thick, woolly hair, nicknamed the 'Colossal woolly mouse'. This achievement is a step towards their ambitious goal of genetically engineering animals to resemble extinct species like the Woolly mammoth and Dodo. The company, led by CEO Ben Lamm and chief scientist Josh Shapiro, has raised over $400 million in funding and plans to eventually move on to editing Asian elephant embryos, the closest living relatives to Woolly mammoths. While independent experts like Bong Go and Vincent Lynch acknowledge the technological feat, some express skepticism about the true conservation benefits of 'de-extinction', arguing it merely changes existing animals. However, experts like Bhanu Telugu see broader applications for precision gene-editing in conservation, animal agriculture, and even fighting human diseases, with Colossal Biosciences already having spun off two healthcare companies.

Key Actions
100 Colossal Biosciences announced gene editing Mouse
80 Colossal Biosciences raised funding
70 Colossal Biosciences unveiled plan
50 Colossal Biosciences spun off companies
Entities Involved
priv
Colossal Biosciences
Colossal Biosciences is the biotech company at the forefront of genetically engineering animals to resemble extinct species, having successfully edited genes in mice embryos and raised over $400 million in funding.
Importance 100.0 Sentiment 70.0
per
Ben Lamm
Ben Lamm is the CEO of Colossal Biosciences and a key spokesperson for the company's de-extinction efforts and its broader applications in healthcare.
Importance 80.0 Sentiment 60.0
oth
Woolly mammoth
The Woolly mammoth is the extinct species that Colossal Biosciences aims to 'revive' through genetic engineering, serving as the primary inspiration for their research.
Importance 70.0 Sentiment 0.0
per
Josh Shapiro
Josh Shapiro is Colossal Biosciences' chief scientist, explaining the process of combining genetic variations in mice to achieve desired traits.
Importance 70.0 Sentiment 60.0
oth
Asian elephant
Asian elephant is the closest living relative to the Woolly mammoth, and Colossal Biosciences plans to edit its embryos in future stages of their de-extinction project, though it is an endangered species.
Importance 60.0 Sentiment 0.0
oth
Mouse
Colossal Biosciences successfully edited seven genes in Mouse embryos to create mice with woolly hair, a significant step in their genetic engineering process.
Importance 50.0 Sentiment 0.0
oth
CRISPR
CRISPR is a new gene-editing technology that makes the process more efficient and easier, as noted by Vincent Lynch, aiding Colossal Biosciences' efforts.
Importance 40.0 Sentiment 0.0
oth
Dodo
The Dodo is another extinct species that Colossal Biosciences plans to revive through genetic engineering, following their work on the Woolly mammoth.
Importance 30.0 Sentiment 0.0
per
Bhanu Telugu
Bhanu Telugu, who studies animal biotechnology at the University of Missouri, is impressed by Colossal Biosciences' technology and sees potential for gene-editing in conservation and agriculture.
Importance 30.0 Sentiment 0.0
per
Vincent Lynch
Vincent Lynch, a biologist at the University of Buffalo, acknowledges the technological coolness of Colossal Biosciences' gene-editing feat in mice.
Importance 30.0 Sentiment 0.0
per
Bong Go
Bong Go, a wildlife and environment expert at the University of Montana, expresses skepticism about the de-extinction efforts, stating that it's not true resurrection but rather changing existing animals.
Importance 30.0 Sentiment 0.0
oth
Thylacine
Colossal Biosciences previously announced a breakthrough in efforts to bring back the extinct Thylacine, indicating their broader de-extinction ambitions.
Importance 20.0 Sentiment 0.0
oth
University of Montana
The University of Montana is the institution where Bong Go, a skeptical expert on de-extinction, is affiliated.
Importance 10.0 Sentiment 0.0
oth
University of Missouri
The University of Missouri is the institution where Bhanu Telugu, an animal biotechnology expert, is affiliated.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.